Fundz

Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel

PUBLIC · GPCRApr 14, 2026

Position

Chief Operating Officer

Company

Structure Therapeutics

Matthew Lang, J.D.
San FranciscoBiotechnologyTherapeuticsPharmaceuticalBiopharma

Description

Structure Therapeutics Inc. has announced the appointment of Matthew Lang, J.D. as Chief Operating Officer and General Counsel

Quick answer

Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel (April 14, 2026). Structure Therapeutics is based in San Francisco, California, United States.

Who is the new Chief Operating Officer at Structure Therapeutics?
Structure Therapeutics named Matthew Lang, J.D. Chief Operating Officer, announced April 14, 2026.
What did Structure Therapeutics announce on April 14, 2026?
Structure Therapeutics Inc. has announced the appointment of Matthew Lang, J.D. as Chief Operating Officer and General Counsel
What does Structure Therapeutics do?
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions...
Where is Structure Therapeutics based?
Structure Therapeutics is based in San Francisco, California, United States.
Which similar companies made leadership changes around the same time?
NRx Pharmaceuticals (April 13, 2026), Abivax (April 12, 2026), BridgeBio Oncology Therapeutics (April 22, 2026) and Minerva Neurosciences (April 2, 2026) also announced leadership changes within 45 days of Structure Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Structure Therapeutics, and when

A new leader at Structure Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Structure Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Structure Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Structure Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Structure Therapeutics

Location

601 Gateway Blvd, Suite 900

San Francisco, California, United States

About

Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, the Company has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Structure Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Phoebe
Senior decision-maker at this company
••••••••@••••••••

See Phoebe's verified email →

Eric
Likely contact at this company
••••••••@••••••••

See Eric's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Structure Therapeutics's next move

Learn about Strategic plan

Structure Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.